DALLAS--(BUSINESS WIRE)--HemoBioTech (OTCBB:HMBT) (www.hemobiotech.com) announced today that their orthogonal (ORTH) technology showed to be extremely effective in elimination of prion proteins that cause mad cow disease (BSE) and a similar disease in humans (vCJD/CJD). The ORTH technology removed prion proteins at a rate of 10 -10 from biological fluids used to make specific pharmaceutical products.
